Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

205 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The risks of adverse events with venlafaxine and mirtazapine versus 'active placebo', placebo, or no intervention for adults with major depressive disorder: a protocol for two separate systematic reviews with meta-analysis and Trial Sequential Analysis.
Jørgensen CK, Juul S, Siddiqui F, Horowitz MA, Moncrieff J, Munkholm K, Hengartner MP, Kirsch I, Gluud C, Jakobsen JC. Jørgensen CK, et al. Among authors: moncrieff j. Syst Rev. 2023 Mar 30;12(1):57. doi: 10.1186/s13643-023-02221-5. Syst Rev. 2023. PMID: 36991504 Free PMC article.
RELEASE (REdressing Long-tErm Antidepressant uSE): protocol for a 3-arm pragmatic cluster randomised controlled trial effectiveness-implementation hybrid type-1 in general practice.
Wallis KA, Donald M, Horowitz M, Moncrieff J, Ware RS, Byrnes J, Thrift K, Cleetus M, Panahi I, Zwar N, Morgan M, Freeman C, Scott I. Wallis KA, et al. Among authors: moncrieff j. Trials. 2023 Sep 28;24(1):615. doi: 10.1186/s13063-023-07646-w. Trials. 2023. PMID: 37770893 Free PMC article.
Antipsychotic dose reduction and discontinuation versus maintenance treatment in people with schizophrenia and other recurrent psychotic disorders in England (the RADAR trial): an open, parallel-group, randomised controlled trial.
Moncrieff J, Crellin N, Stansfeld J, Cooper R, Marston L, Freemantle N, Lewis G, Hunter R, Johnson S, Barnes T, Morant N, Pinfold V, Smith R, Kent L, Darton K, Long M, Horowitz M, Horne R, Vickerstaff V, Jha M, Priebe S. Moncrieff J, et al. Lancet Psychiatry. 2023 Nov;10(11):848-859. doi: 10.1016/S2215-0366(23)00258-4. Epub 2023 Sep 28. Lancet Psychiatry. 2023. PMID: 37778356 Free article. Clinical Trial.
An ethics analysis of antipsychotic dose reduction and discontinuation: Principles for supporting recovery from psychosis.
Allott K, Pert A, Rattray A, Cooper RE, Winther Davy J, Grünwald L, Horowitz M, Moncrieff J, Rosema BS, Simmons M, Stainton A, Stürup AE, Killackey E; TAPER International Research Consortium. Allott K, et al. Among authors: moncrieff j. Psychiatr Rehabil J. 2024 Dec;47(4):291-302. doi: 10.1037/prj0000599. Epub 2024 Jul 25. Psychiatr Rehabil J. 2024. PMID: 39052404 Review.
Less focus on symptom scales in psychiatric trials: it is time to ensure research equality between psychiatry and other medical specialities.
Juul S, Siddiqui F, Faltermeier P, Petersen JJ, Kamp CB, Jakobsen RH, Thabane L, Moncrieff J, Horowitz M, Samaan Z, Hengartner MP, Mbuagbaw L, Olsen MH, Gluud C, Jakobsen JC. Juul S, et al. Among authors: moncrieff j. Lancet Reg Health Eur. 2024 Jul 2;43:100993. doi: 10.1016/j.lanepe.2024.100993. eCollection 2024 Aug. Lancet Reg Health Eur. 2024. PMID: 39055683 Free PMC article. No abstract available.
205 results